Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Autologous platelet concentrates can effectively treat oral lichen planus like topical steroids.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

MM-CEP/NLCs could effectively treat lung inflammation.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Certain drugs that block specific enzymes can help treat prostate diseases.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

PRP injections don't significantly help with mild to moderate erectile dysfunction.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Analog 23 is a promising compound for prostate cancer treatment.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.